Hi,
Nobody mentioned the newest deal happened yesterday in US
10.8 B for a clinical-stage biotech is quite a lot of money, imo.
Well, it seems that very good times are coming, once the P2 results (positive) for NNZ2591 will be released
US10.8 bil would mean a price/share of US83 for Neuren (AU$124)
GLTA
Merck acquires Prometheus Biosciences in $10.8bn deal (biopharma-reporter.com)
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.43 |
Change
0.230(1.62%) |
Mkt cap ! $1.797B | |||
| Open | High | Low | Value | Volume |
| $14.22 | $14.55 | $14.10 | $3.421M | 237.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 580 | $14.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.44 | 945 | 11 |
View Market Depth
| Last trade - 14.56pm 04/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |